Skip to main content

1 Result(s)

within Xu-bin Duan Remove this filter

and

  1. No Access

    Article

    WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice

    The global prevalence of nonalcoholic steatohepatitis (NASH) increases incredibly. NASH ends up to advanced liver disease, which is highly threatening to human health. Currently, treatment of NASH is very limi...

    Ying-sheng Gao, Min-yi Qian, Qiang-qiang Wei, Xu-bin Duan… in Acta Pharmacologica Sinica (2020)